Thalia Marie Blicher

984 total citations · 1 hit paper
10 papers, 498 citations indexed

About

Thalia Marie Blicher is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thalia Marie Blicher has authored 10 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thalia Marie Blicher's work include Diabetes Treatment and Management (6 papers), Heart Failure Treatment and Management (2 papers) and Acute Myocardial Infarction Research (2 papers). Thalia Marie Blicher is often cited by papers focused on Diabetes Treatment and Management (6 papers), Heart Failure Treatment and Management (2 papers) and Acute Myocardial Infarction Research (2 papers). Thalia Marie Blicher collaborates with scholars based in Denmark, United Kingdom and United States. Thalia Marie Blicher's co-authors include Julio Rosenstock, Pierre Sérusclat, Andreas L. Birkenfeld, Srikanth Deenadayalan, Hirotaka Watada, Melanie J. Davies, Jacob Jacobsen, Rafael Violante, Flemming L. Søndergaard and Morten Donsmark and has published in prestigious journals such as JAMA, Diabetes and European Heart Journal.

In The Last Decade

Thalia Marie Blicher

10 papers receiving 481 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea

2019 302 citations Julio Rosenstock, Andreas L. Birkenfeld et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thalia Marie Blicher Denmark	7	384	286	95	86	45	10	498
Trine Saugstrup Denmark	6	405 1.1×	284 1.0×	124 1.3×	98 1.1×	23 0.5×	8	611
Astrid Breitschaft Denmark	11	406 1.1×	191 0.7×	165 1.7×	123 1.4×	19 0.4×	17	542
N. Vachharajani United States	6	606 1.6×	361 1.3×	108 1.1×	374 4.3×	36 0.8×	12	738
P Andréadis Greece	6	298 0.8×	154 0.5×	64 0.7×	87 1.0×	28 0.6×	14	402
Fred Yang United States	9	771 2.0×	386 1.3×	166 1.7×	300 3.5×	33 0.7×	17	867
Chiaki Kuriyama Japan	9	343 0.9×	178 0.6×	32 0.3×	267 3.1×	13 0.3×	13	464
Thinzar Min United Kingdom	11	319 0.8×	153 0.5×	102 1.1×	145 1.7×	62 1.4×	31	491
Ros Swallow United Kingdom	5	500 1.3×	246 0.9×	71 0.7×	369 4.3×	29 0.6×	6	685
Julie Derving Karsbøl Denmark	9	1.1k 2.8×	737 2.6×	290 3.1×	277 3.2×	31 0.7×	15	1.2k
Josselin Nespoux United States	6	334 0.9×	150 0.5×	30 0.3×	220 2.6×	49 1.1×	14	491

Countries citing papers authored by Thalia Marie Blicher

Since Specialization

Citations

This map shows the geographic impact of Thalia Marie Blicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thalia Marie Blicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thalia Marie Blicher more than expected).

Fields of papers citing papers by Thalia Marie Blicher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thalia Marie Blicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thalia Marie Blicher. The network helps show where Thalia Marie Blicher may publish in the future.

Co-authorship network of co-authors of Thalia Marie Blicher

This figure shows the co-authorship network connecting the top 25 collaborators of Thalia Marie Blicher. A scholar is included among the top collaborators of Thalia Marie Blicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thalia Marie Blicher. Thalia Marie Blicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Mosenzon, Ofri, Signe Rosenlund, Jan W. Eriksson, et al.. (2019). 1004-P: Oral Semaglutide vs. Placebo in Patients with Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5. Diabetes. 68(Supplement_1). 8 indexed citations

Rosenstock, Julio, Andreas L. Birkenfeld, Thalia Marie Blicher, et al.. (2019). SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial. Journal of the Endocrine Society. 3(Supplement_1). 1 indexed citations

Rosenstock, Julio, et al.. (2019). 111-LB: Oral Semaglutide vs. Sitagliptin: Efficacy by Baseline HbA1c and Background OAD in PIONEER 3. Diabetes. 68(Supplement_1). 1 indexed citations

Rosenstock, Julio, Andreas L. Birkenfeld, Thalia Marie Blicher, et al.. (2019). Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea. JAMA. 321(15). 1466–1466. 302 indexed citations breakdown →

Granhall, Charlotte, Morten Donsmark, Thalia Marie Blicher, et al.. (2018). Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes. Clinical Pharmacokinetics. 58(6). 781–791. 120 indexed citations

Blicher, Thalia Marie, Kristine Hommel, Søren Lund Kristensen, et al.. (2014). Benefit of Clopidogrel Therapy in Patients With Myocardial Infarction and Chronic Kidney Disease—A Danish Nation‐Wide Cohort Study. Journal of the American Heart Association. 3(4). 11 indexed citations

Blicher, Thalia Marie, et al.. (2013). Introducing an adverse drug event manager. European Journal of Hospital Pharmacy. 20(2). 78–81. 17 indexed citations

Blicher, Thalia Marie, Kristine Hommel, Jonas Bjerring Olesen, et al.. (2013). Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: a Danish nation-wide cohort study. European Heart Journal. 34(37). 2916–2923. 22 indexed citations

Kristensen, Søren Lund, Emil Loldrup Fosbøl, Anne‐Lise Kamper, et al.. (2012). Use of nonsteroidal anti‐inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study. Pharmacoepidemiology and Drug Safety. 21(4). 428–434. 12 indexed citations

10.

Blicher, Thalia Marie, Henrik L. Jørgensen, Peter Schwarz, & Hans Christian Wulf. (2012). Low levels of vitamin D are associated with increased mortality in patients attending a university hospital in Denmark. Scandinavian Journal of Clinical and Laboratory Investigation. 73(1). 24–28. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact